Results for “ ”

Entry Author Date Location
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Allergan to Acquire Fat-Busting Medical Tech Firm Zeltiq for $2.4B 02/13/17 San Francisco
Dear Tom Price: Bundled Payments Help Patients and Reduce Costs 02/11/17 Boston
Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights 02/10/17 Seattle
Senate Confirms Price for HHS, But Stock Deals Still Raise Questions 02/10/17 National
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs 02/10/17 Boston
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation 02/10/17 National
San Francisco Appeals Court Upholds Stay on Trump’s Travel Ban—For Now 02/09/17 National
Xconomy Is Growing: We Need Great Salespeople in SF, Texas, and NY 02/09/17 National
Acorda Touts Success in Parkinson’s Drug Study, Awaits Safety Data 02/09/17 New York
Trump’s Immigration Policies Threaten to Thwart Economic Growth 02/07/17 Detroit Ann Arbor
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Kentucky Biotech CEO’s Message For McConnell: I’ll Be Muslim, Too 02/07/17 National
Tesora Bought by Stratoscale in Data Center Tech Consolidation 02/06/17 Boston
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
No Details Yet, But Amgen Touts Success in Big Heart Drug Study 02/02/17 San Francisco
Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing 02/02/17 San Diego
Insurer UHC Will Cover Biogen Spine Drug, But With Limits And Proof 02/02/17 Boston
Royalty Pharma Pays $90M to Cytokinetics for Heart Drug Royalties 02/02/17 San Francisco
Seed-Stage Deals Show Growing Diversity of Agtech Investments 02/01/17 Raleigh Durham
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Datto Buys Open Mesh to Build Out Networking Business 01/31/17 Boston
WorkFusion Using $35M in New Cash to Expand in Business Automation 01/31/17 New York
Still No Official Word From Biopharma Groups About Trump Travel Ban 01/31/17 National
Ex-Xerox CTO Vandebroek Named Chief Operating Officer of IBM Research 01/30/17 Boston
Cybersecurity in 2017: Goal, Illusion, or Oxymoron? 01/30/17 Seattle
Non-Profit Aims For Market Transparency In K-12 Edtech Purchases 01/30/17 San Francisco
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
Page 3 of 245 « previous page · next page »